Streetbeat News

Stock Prices

AMLX

Amylyx Pharma (NASDAQ:AMLX) has been the subject of diverse analyst ratings over the past three months, with a total of 6 analysts offering perspectives ranging from bullish to bearish. The average 12-month price target for AMLX has significantly declined to $10.67 from a previous average of $31.67, indicating a 66.31% decrease. Analyst actions include maintaining, lowering, and raising ratings and price targets, reflecting responses to market dynamics and company performance. Amylyx Pharma, a clinical-stage pharmaceutical company, has shown remarkable revenue growth of 395.54% as of December 31, 2023, but trails behind industry peers in the Health Care sector. The company's financial performance is highlighted by its net margin of 4.36%, ROE of 1.11%, ROA of 0.96%, and a low debt-to-equity ratio of 0.01.

Portfolio Pulse from Benzinga Insights

April 08, 2024 | 12:00 pm

NXPI

RACE

Ferrari NV (NYSE:RACE) has launched E-Cells Lab, a research center focused on electrochemistry for battery technology, in collaboration with the University of Bologna. The lab aims to advance knowledge in lithium cell materials and their properties. Findings from the lab will be shared with NXP Semiconductors N.V. (NASDAQ:NXPI), a technology partner. The research will enhance the performance of batteries for Ferrari's Maranello plants. RACE shares rose 0.66% in premarket trading.

Portfolio Pulse from Shivani Kumaresan

April 08, 2024 | 11:58 am

AMD

BABA

INTC

JD

NVDA

ONLN

PGJ

Alibaba Group Holding Ltd (NYSE:BABA) announced significant price reductions for its cloud services, extending discounts internationally. This follows a price cut in China that sparked a pricing battle with JD.com Inc (NASDAQ:JD). The U.S. has further restricted China's access to advanced AI processors, impacting companies like Alibaba. Despite challenges, Alibaba seeks alternatives and plans to enhance its cloud business. Intel Corp (NASDAQ:INTC) supplied chips to Huawei, countering U.S. sanctions, while Advanced Micro Devices Inc (NASDAQ:AMD) and Nvidia Corp (NASDAQ:NVDA) are also mentioned in the context of U.S. export controls. Alibaba's stock is available through Invesco Golden Dragon China ETF (NASDAQ:PGJ) and ProShares Online Retail ETF (NYSE:ONLN).

Portfolio Pulse from Anusuya Lahiri

April 08, 2024 | 11:55 am

PLUR

Pluri shares surged following the announcement of a new patent grant for a system and methods aimed at expanding and activating immune cells on a large scale. This development could potentially enhance the company's offerings in the biotechnology sector, signaling a positive outlook for its future operations and market position.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:51 am

OCGN

Ocugen's stock price increased following the announcement of the U.S. FDA's clearance for an IND amendment, allowing the company to initiate a Phase 3 clinical trial of OCU400.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:47 am

UCAR

U Power shares surged following the announcement of a formal commercial rollout of its battery-swapping and sharing model for two-wheeled and light four-wheeled electric vehicles in Wuhu, Anhui Province, China.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:41 am

GLD

SPY

U.S. stock markets ended higher on April 5th, driven by a strong jobs report, suggesting the Federal Reserve may hold off on reducing interest rates. Asian markets were mixed, with gains in Japan, Australia, and India, but declines in China. European markets rose, and gold hit a new high at $2,350. U.S. futures were slightly down in early trading.

Portfolio Pulse from Akanksha Bakshi

April 08, 2024 | 11:38 am

IREN

Iris Energy's stock is trading higher following the announcement of an upsized and extended AI cloud services agreement with Poolside. The increase in stock price may also be attributed to a recent rise in the price of Bitcoin.

Portfolio Pulse from Benzinga Newsdesk

April 08, 2024 | 11:36 am

TSLA

Tesla Inc. (TSLA) shares are rebounding in premarket trading after a 6% drop last week due to rumors of a scrapped low-cost EV project. Despite CEO Elon Musk's denial, the stock fell 3.63% on Friday. The rebound, with shares up 1.86% to $167.96, is attributed to Musk's announcement of a robotaxi unveiling on Aug. 8, which has analysts optimistic about Tesla's full-self driving software. Gene Munster of Deepwater Asset Management supports Tesla's focus on robotaxis, predicting their deployment by 2027. Technical factors and the stock's bounce off a support level also contribute to the positive outlook, with investors eyeing the upcoming Q1 earnings report on April 23rd.

Portfolio Pulse from Shanthi Rexaline

April 08, 2024 | 11:32 am

DCO

Ducommun Inc (NYSE:DCO) shares surged after receiving an unsolicited acquisition proposal from Albion River LLC for $60.00 per share in cash. The Board of Directors is reviewing the offer to assess its alignment with shareholder interests. Ducommun, a provider of manufacturing solutions in aerospace, defense, and industrial sectors, reported a revenue of $757 million in 2023, with a market capitalization increase to $760 million from $605 million in 2022. RBC Capital Markets and Simpson Thacher & Bartlett LLP are advising Ducommun on this matter. DCO shares rose 14.2% to $55.48 in premarket trading.

Portfolio Pulse from Shivani Kumaresan

April 08, 2024 | 11:32 am